News

Gea Pharma has expanded its agency representation in India with a new agreement with Ace Technologies of Mumbai, India to sell its range of Gea Lyophil pharmaceutical (Gea

The Economic times has reported that India is planing to file a case against the European Union at the World Trade Organisation (WTO). India plans to go to

Spectrum Pharmaceuticals (Spectrum) and Handok Pharmaceuticals (Handok) have entered into collaboration for the development and commercialisation of apaziquone in South Korea. Apaziquone is an antineoplastic agent currently being

Inovio Biomedical has reported that a combination of synthetic consensus H1N1, H2N2, H3N2, and H5N1 influenza vaccine candidates achieved protective antibody responses against several different influenza sub-types and

Circassia has reported positive results from a recently completed phase II clinical study of ToleroMune cat allergy therapy, which successfully identified the optimal dosing regimens to progress into

Roche has established Roche Pharma Partnering Asia Office in China on November 1, 2009. The New facility will help create network alliances worldwide. Reportedly, the move is a

Amgen has licensed the exclusive right to use the ImmunoGen’s maytansinoid Targeted Antibody Payload (TAP) technology to develop anticancer therapeutics for an undisclosed target. This is the second

Boston Scientific has received 510(k) clearance from the FDA and CE Mark approval to market its WallFlex fully covered esophageal stent for the treatment of malignant esophageal strictures

Pfizer has received FDA approval for Revatio (sildenafil) injection, an intravenous formulation of Revatio. Revatio is the FDA-approved phosphodiesterase-5 (PDE5) inhibitor available in both tablet and intravenous formulations.